Catecholamine-secreting neuroendocrine tumors that arise from chromaffin cells of the adrenal medulla are known as pheochromocytomas, and are named paragangliomas when arising from the neuroendocrine cells of the extra-adrenal autonomic paraganglia. Paragangliomas are less often hormonally active than pheochromocytomas but are more likely to be malignant \[[@B1]\]. Most paragangliomas are intra-abdominal and adjacent to the adrenal glands. Intrathoracic paragangliomas are more often located in the anterior mediastinum, and when associated with the spine they tend to be located in the cauda equine \[[@B2]\]. Very few cases of presurgical embolization of paragangliomas located in the thoracic spine have been reported \[[@B3], [@B4], [@B5], [@B6], [@B7]\]. To our knowledge this is the f irst report of Onyx embolization of a malignant, functioning thoracic paraganglioma.

CASE REPORT
===========

A 19-year-old man with 6-year history of chest pain and 6 months of progressive paraplegia with associated hypertension was admitted for further work up of a known mass in the thoracic spine. MRI findings evidenced a thoracic tumor extending from T4 to T9 with an associated T6 vertebral fracture and a L3 metastatic lesion ([Fig. 1A and 1B](#F1){ref-type="fig"}). Iodine-123 metaiodobenzylguanidine scintigraphy (I-123 MIBG) showed intense uptake within the same areas ([Fig. 1C](#F1){ref-type="fig"}). A spinal digital subtraction angiography (DSA) showed a prominent tumor blush, with arterial feeders arising from the right T5 through T10 intercostal arteries. The most prominent arterial feeders were T7 through T9 ([Fig. 2A](#F2){ref-type="fig"}).

An ultrasound guided biopsy confirmed it to be a paraganglioma ([Fig. 3A and 3B](#F3){ref-type="fig"}). There was no history of any associated familial syndromes and genetic testing did not display any known abnormality.

A functional, malignant thoracic paraganglioma was diagnosed and sequential alpha and beta blocker was started in preparation for a staged combined treatment. The patient underwent a successful presurgical tumor embolization of arterial feeders coming from the right T7, T8 and T9 intercostal arteries in three consecutive days, using liquid embolic material (Onyx, Covidien Inc., Irvine, CA) through a 4×10 mm Scepter-C balloon catheter (Microvention Inc., Tustin, CA). The presurgical augmented embolization archived more than 90% reduction of the tumor blush ([Fig. 2B](#F2){ref-type="fig"}).

The surgical treatment consisted of two stages. In the first surgery the patient had a partial T5, complete T6, partial T7 laminectomy, and pedicle screw fixation of T4, T5, T7, and T8 with posterolateral fusion. The surgery lasted 7.5 hours with an estimated blood loss of 700 ml. A second surgery five days later consisted of a right posterolateral thoracotomy and total gross resection of the thoracic paraganglioma ([Fig. 3C](#F3){ref-type="fig"}). It lasted 7 hours with an estimated blood loss of 4500 ml requiring 4 units of packed blood cells, 10 units of platelets, 4 units of fresh frozen plasma and 500 ml of albumin. Of note, prior to the admission the patient had an attempted tumor resection through a right thoracotomy in another hospital where the procedure was abandoned due to a significant blood loss. Microscopic examination of the resected specimen showed coagulative necrosis of the tumor with the embolic material completely occluding an artery and some viable tumor cells after the embolization ([Fig. 3D and 3E](#F3){ref-type="fig"}).

Hemodynamic instability was observed during every procedure despite appropriate alpha and beta blockade. This coincided with the manipulation of the tumor, either vascular or mechanic. The response was less intense after every intervention and was managed pharmacologically without complications ([Table 1](#T1){ref-type="table"}).

DISCUSSION
==========

This is a case of a large thoracic, functional malignant paraganglioma treated with trans-arterial Onyx embolization of its three major vascular feeders and two subsequent surgeries. Surgical excision is the gold standard treatment for paragangliomas. There is no consensus in the definition of malignant paraganglioma and the only consistent criterion among the proposed indicators is the presence of metastatic disease. More importantly, no histological criteria have shown to be a reliable marker of aggression.

The hypervascular nature of these tumors associated with other characteristics, like location and catecholamine secretion make their resection challenging. For this reason presurgical embolization can be a valuable and safe tool in the management of these tumors as it has been shown to reduce the risk of catecholamines release during surgical manipulation of the tumor, decrease the intraoperative blood loss, and decrease the number of transfusions, therefore reducing the operative time, complications and local recurrence \[[@B4], [@B5], [@B8]\].

In our case, each presurgical embolization resulted in a reduced catecholamine secretion as evidenced by the subsequent reduction in the magnitude of the hypertensive response. Although there was a significant blood loss during the surgical excision of the tumor in our case, we believe that it would have been more prominent without the embolization. As discussed by other authors, the estimated blood loss and operative time are influenced by other factors other than the embolization, like invasiveness of the procedure and surgical approach \[[@B9]\].

To date, only five cases of presurgical embolization of thoracic paragangliomas have been reported \[[@B3], [@B4], [@B5], [@B6], [@B7]\]. Only one of them was functional, and differs from our case in that it was a metastatic lesion involving one vertebral level \[[@B5]\]. The embolic materials reported included Gelfoam and the most commonly used Polyvinyl alcohol, all with positive results. Ghobrial et al showed the feasibility of trans-arterial embolization with Onyx in the management of spinal tumors although most of their cases represented by metastatic renal cell carcinomas. When compared with other agents, Onyx demonstrated higher rates of angiographic obliteration and intraoperative bleeding reduction, although the difference did not reach statistical significance \[[@B8]\]. Advantages of Onyx are related to its properties that permit more control and longer injections and deeper penetration through the tumor vascularity. It also gives excellent surgical handling properties that help with the tumor resection \[[@B8], [@B10]\].

In summary, the treatment goal of functional thoracic paragangliomas is surgical resection. Surgery however is very challenging due to hemodynamic instability and prominent hemorrhagic tendency. Pre-surgical embolization significantly helps to decrease these adverse events. The combination of Onyx with the Scepter C balloon seems to be a good option when aggressive embolization of functional thoracic paraganglioma is intended.
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![Diagnostic imaging. **A.** Sagittal T2-weighted image demonstrating a pathologic T6 compression fracture and cord edema. **B.** Coronal STIR (upper) showing a paraspinal and intraspinal extradural heterogeneous enhancing mass extending from T4-T9 causing widening of the neural foramina and severe canal stenosis. There was a separate metastatic hyperintense lesion in L3 vertebral body (lower **B**). **C.** I-123 MIBG whole body AP view demonstrated intense uptake within the large right paravertebral mass and separate L3 lytic lesion.](ni-10-34-g001){#F1}

![Digital Subtraction Angiography. **A.** Diagnostic angiogram in the anterior-posterior view shows a highly vascular tumor. Note the prominent tumor blush within the main feeders (T7-T9). **B.** Control angiogram after each ONYX embolization reveals complete devascularization with no residual tumor blush.](ni-10-34-g002){#F2}

![Pathology. **A.** Nests of tumor cells (Zellballen) composed of uniform cells with round nuclei, eosinophil cytoplasm in a highly vascular stroma (Haematoxylin and Eosin, 40×). **B.** Inmmunohistochemical staining of the tumor showing positivity for Chromogranin (10×). **C.** A tumor measuring 10×7×3 cm resected in the second surgery. Microscopic examination of the resected mass evidence **D**) 50% coagulative necrosis of the tumor (black arrow) with the embolic material completely occluding an artery, and **E**) some viable tumor cells after the embolization (black arrows) (Haematoxylin and Eosin, 10×).](ni-10-34-g003){#F3}

###### Hemodynamic Changes Observed During the Staged Treatment

![](ni-10-34-i001)

  Procedure                                          Highest Blood Pressure (mmHg)   Heart Rate (bpm)   Medications used to control blood pressure
  -------------------------------------------------- ------------------------------- ------------------ --------------------------------------------
  T8 embolization                                    224/145                         105                Labetalol
  Esmolol                                                                                               
  T9 embolization                                    220/100                         61                 Hydralazine
  Nicardipine drip                                                                                      
  Nitroprusside drip                                                                                    
  T7 embolization                                    180/84                          60                 Labetalol drip
  Nicardipine drip                                                                                      
  Surgical decompression with spinal stabilization   200/110                         92                 Hydralazine
  Esmolol                                                                                               
  Labetalol                                                                                             
  Nitroprusside drip                                                                                    
  Tumor resection                                    190/100                         100                Labetalol
  Esmolol                                                                                               
  Nitroprusside                                                                                         
  Nicardipine                                                                                           
